reference_id,authors,title,journal,year,volume,citation_footer,citation_type,citation,urls,pubmed_id,doi,header,reference_type,study_id,exclusion_reason,PUBMED_ID_TITLE_AUTHORS,PUBMED_ID_TITLE,PUBMED_ID_S2,N_CITATIONS,S2_PDF_LINK,CORE_PDF_LINK,PUBMED_ID
CD015322-bib-0001,NCT02447991. ,Rizatriptan for episodic dizziness in vestibular migraine,,,, [CLINICALTRIALS.GOV: NCT02447991]   ,['citation-other'], NCT02447991. Rizatriptan for episodic dizziness in vestibular migraine [A phase II/III trial on rizatriptan for vestibular migraine]. http://clinicaltrials.gov/show/NCT02447991 (first received 19 May 2015). CENTRAL [CLINICALTRIALS.GOV: NCT02447991]    ,[''],,, NCT02447991 {published data only}  ,included,CD015322-bbs2-0001,,,,,,,,
CD015322-bib-0002,"Neuhauser H, Radtke A, von Brevern M, Lempert T. ",Zolmitriptan for treatment of migrainous vertigo: a pilot randomized placebo-controlled trial, Neurology ,2003,60,    ,['citation-journal']," Neuhauser H, Radtke A, von Brevern M, Lempert T. Zolmitriptan for treatment of migrainous vertigo: a pilot randomized placebo-controlled trial.  Neurology 2003;60(5):882-3. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1212/01.WNL.0000049476.40047.A3', 'https://www.ncbi.nlm.nih.gov/pubmed/12629256', 'https://scholar.google.com/scholar_lookup?title=Zolmitriptan+for+treatment+of+migrainous+vertigo:+a+pilot+randomized+placebo-controlled+trial+&author=H+Neuhauser&author=A+Radtke&author=M+Brevern&author=T+Lempert&publication_year=2003&hl=en']",12629256,https://doi.org/10.1212/01.WNL.0000049476.40047.A3, Neuhauser 2003 {published data only}  ,included,CD015322-bbs2-0002,,12629256,12629256,12629256,147,,,12629256
CD015322-bib-0003,ACTRN12616000683437. ,A test of the balance system in vestibular migraine,,,,   ,['citation-other'], ACTRN12616000683437. A test of the balance system in vestibular migraine [Diagnostic value of oVEMPs and cVEMPs in patients with vestibular migraine but without Meniere's disease]. http://anzctr.org.au/ACTRN12616000683437.aspx (first received 25 May 2016). CENTRAL    ,[''],,, ACTRN12616000683437 {published data only}  ,excluded,CD015322-bbs2-0003, This study is not an RCT.  ,,,,,,,
CD015322-bib-0004,"Byun YJ, Levy DA, Nguyen SA, Brennan E, Rizk HG. ",Treatment of vestibular migraine: a systematic review and meta-analysis, Laryngoscope ,2021,131,    ,['citation-journal']," Byun YJ, Levy DA, Nguyen SA, Brennan E, Rizk HG. Treatment of vestibular migraine: a systematic review and meta-analysis.  Laryngoscope 2021;131(1):186-94. CENTRAL [EMBASE: 2004334398]    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1002/lary.28546', 'https://www.ncbi.nlm.nih.gov/pubmed/32083732', 'https://scholar.google.com/scholar_lookup?title=Treatment+of+vestibular+migraine:+a+systematic+review+and+meta-analysis&author=YJ+Byun&author=DA+Levy&author=SA+Nguyen&author=E+Brennan&author=HG+Rizk&publication_year=2021&hl=en']",32083732,https://doi.org/10.1002/lary.28546, Byun 2021 {published data only}  ,excluded,CD015322-bbs2-0004," This article is a systematic review, not an RCT. The reference list has been checked to ensure that any relevant RCTs are included in this review.   ",,,32083732,68,,,32083732
CD015322-bib-0005,ChiCTR1800014766. ,Multi-center clinical study of patients with vertigo and migraine,,,,   ,['citation-other'], ChiCTR1800014766. Multi-center clinical study of patients with vertigo and migraine [Clinical characteristics and evaluation of vestibular eye movements in patients with vestibular migraine]. http://www.chictr.org.cn/showproj.aspx?proj=24833 (first received 3 February 2018). CENTRAL    ,[''],,, ChiCTR1800014766 {published data only}  ,excluded,CD015322-bbs2-0005, This study is not an RCT.  ,,,,,,,
CD015322-bib-0006,"Furman JM, Marcus DA. ",A pilot study of rizatriptan and visually-induced motion sickness in migraineurs, International Journal of Medical Sciences ,2009,6,    ,['citation-journal']," Furman JM, Marcus DA. A pilot study of rizatriptan and visually-induced motion sickness in migraineurs.  International Journal of Medical Sciences 2009;6(4):212-7. [CENTRAL: CN-00721128] CENTRAL [PMID: 19680473]    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.7150/ijms.6.212', 'https://www.ncbi.nlm.nih.gov/pubmed/19680473', 'https://scholar.google.com/scholar_lookup?title=A+pilot+study+of+rizatriptan+and+visually-induced+motion+sickness+in+migraineurs&author=JM+Furman&author=DA+Marcus&publication_year=2009&hl=en']",19680473,https://doi.org/10.7150/ijms.6.212, Furman 2009 {published data only}  ,excluded,CD015322-bbs2-0006," This study is not an assessment of medications used to treat acute attacks of vestibular migraine. Instead, it aims to assess whether prophylactic treatment with triptans might improve motion sickness symptoms in those with vestibular migraine, when subjected to a vestibular stimulus.   ",19680473,19680473,19680473,18,https://www.medsci.org/v06p0212.pdf,,19680473
CD015322-bib-0007,"Furman JM, Marcus DA, Balaban CD. ",Rizatriptan reduces vestibular-induced motion sickness in migraineurs, Journal of Headache and Pain ,2011,12,    ,['citation-journal']," Furman JM, Marcus DA, Balaban CD. Rizatriptan reduces vestibular-induced motion sickness in migraineurs.  Journal of Headache and Pain 2011;12(1):81-8. [CENTRAL: CN-00802591] CENTRAL [EMBASE: 2011-05255-012] [PMID: 20862509]    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1007/s10194-010-0250-z', 'https://www.ncbi.nlm.nih.gov/pubmed/20862509', 'https://scholar.google.com/scholar_lookup?title=Rizatriptan+reduces+vestibular-induced+motion+sickness+in+migraineurs&author=JM+Furman&author=DA+Marcus&author=CD+Balaban&publication_year=2011&hl=en']",20862509,https://doi.org/10.1007/s10194-010-0250-z, Furman 2011 {published data only}NCT00360282  ,excluded,CD015322-bbs2-0007," This study is not an assessment of medications used to treat acute attacks of vestibular migraine. Instead, it aimed to assess whether prophylactic treatment with triptans might improve motion sickness symptoms in those with vestibular migraine, when subjected to a vestibular stimulus.   ",20862509,20862509,20862509,71,https://thejournalofheadacheandpain.biomedcentral.com/counter/pdf/10.1007/s10194-010-0250-z,,20862509
CD015322-bib-0008,NCT00360282. ,Does a migraine medication decrease rotational motion sickness in people suffering from migraines?,,,,   ,['citation-other'], NCT00360282. Does a migraine medication decrease rotational motion sickness in people suffering from migraines? [Effect of rizatriptan on rotational motion sickness in migraineurs]. https://clinicaltrials.gov/show/nct00360282 (first received August 2006). [CENTRAL: CN-00856751] CENTRAL    ,[''],,, Furman 2011 {published data only}NCT00360282  ,excluded,CD015322-bbs2-0007," This study is not an assessment of medications used to treat acute attacks of vestibular migraine. Instead, it aimed to assess whether prophylactic treatment with triptans might improve motion sickness symptoms in those with vestibular migraine, when subjected to a vestibular stimulus.   ",,,,,,,
CD015322-bib-0009,"Hou M, Xing H, Li C, Wang X, Deng D, Li J, et al. ","Short-term efficacy and safety of lasmiditan, a novel 5-HT1F receptor agonist, for the acute treatment of migraine: a systematic review and meta-analysis", Journal of Headache and Pain ,2020,21,    ,['citation-journal']," Hou M, Xing H, Li C, Wang X, Deng D, Li J, et al. Short-term efficacy and safety of lasmiditan, a novel 5-HT1F receptor agonist, for the acute treatment of migraine: a systematic review and meta-analysis.  Journal of Headache and Pain 2020;21(1):66. CENTRAL [PMID: 32503415]    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1186/s10194-020-01138-x', 'https://www.ncbi.nlm.nih.gov/pubmed/32503415', 'https://scholar.google.com/scholar_lookup?title=Short-term+efficacy+and+safety+of+lasmiditan,+a+novel+5-HT1F+receptor+agonist,+for+the+acute+treatment+of+migraine:+a+systematic+review+and+meta-analysis+&author=M+Hou&author=H+Xing&author=C+Li&author=X+Wang&author=D+Deng&author=J+Li&publication_year=2020&hl=en']",32503415,https://doi.org/10.1186/s10194-020-01138-x, Hou 2020 {published data only}  ,excluded,CD015322-bbs2-0008," This is a systematic review, not an RCT. The reference list has been checked to ensure that any relevant articles have been included in this review.   ",,,32503415,27,https://thejournalofheadacheandpain.biomedcentral.com/track/pdf/10.1186/s10194-020-01138-x,,32503415
CD015322-bib-0010,"Marcus DA, Furman JM. ","Prevention of motion sickness with rizatriptan: a double-blind, placebo-controlled pilot study", Medical Science Monitor ,2006,12,    ,['citation-journal']," Marcus DA, Furman JM. Prevention of motion sickness with rizatriptan: a double-blind, placebo-controlled pilot study.  Medical Science Monitor 2006;12(1):PI1-7. [CENTRAL: CN-00553748] CENTRAL [EMBASE: 2006039907] [PMID: 16369474]    PubMed     Google Scholar     ","['', 'https://www.ncbi.nlm.nih.gov/pubmed/16369474', 'https://scholar.google.com/scholar_lookup?title=Prevention+of+motion+sickness+with+rizatriptan:+a+double-blind,+placebo-controlled+pilot+study+&author=DA+Marcus&author=JM+Furman&publication_year=2006&hl=en']",16369474,, Marcus 2006 {published data only}  ,excluded,CD015322-bbs2-0009," This study is not an assessment of medications used to treat acute attacks of vestibular migraine. Instead, it aimed to assess whether prophylactic treatment with triptans might improve motion sickness symptoms in those with vestibular migraine, when subjected to a vestibular stimulus.   ",16369474,16369474,,,,,16369474
CD015322-bib-0011,"Akerman S, Goadsby PJ. ",Dopamine and migraine: biology and clinical implications, Cephalgia ,2007,27,    ,['citation-journal']," Akerman S, Goadsby PJ. Dopamine and migraine: biology and clinical implications.  Cephalgia 2007;27:1308-14.    Link to article     Google Scholar     ","['https://doi.org/10.1111/j.1468-2982.2007.01478.x', 'https://scholar.google.com/scholar_lookup?title=Dopamine+and+migraine:+biology+and+clinical+implications&author=S+Akerman&author=PJ+Goadsby&publication_year=2007&hl=en']",,https://doi.org/10.1111/j.1468-2982.2007.01478.x, Akerman 2007 ,additional,CD015322-bbs2-0010,,17970991,17970991,17970991,152,,,17970991
CD015322-bib-0012,"Bernstein C, Burstein R. ",Sensitization of the trigeminovascular pathway: perspective and implications to migraine pathophysiology, Journal of Clinical Neurology ,2012,8,    ,['citation-journal']," Bernstein C, Burstein R. Sensitization of the trigeminovascular pathway: perspective and implications to migraine pathophysiology.  Journal of Clinical Neurology 2012;8(2):89-99. [DOI: 10.3988/jcn.2012.8.2.89]    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.3988/jcn.2012.8.2.89', 'https://www.ncbi.nlm.nih.gov/pubmed/22787491', 'https://scholar.google.com/scholar_lookup?title=Sensitization+of+the+trigeminovascular+pathway:+perspective+and+implications+to+migraine+pathophysiology+&author=C+Bernstein&author=R+Burstein&publication_year=2012&hl=en']",22787491,https://doi.org/10.3988/jcn.2012.8.2.89, Bernstein 2012 ,additional,CD015322-bbs2-0011,,22787491,22787491,22787491,309,https://doi.org/10.3988/jcn.2012.8.2.89,,22787491
CD015322-bib-0013,"Bigal ME, Bordini CA, Tepper SJ, Speciali JG. ","Intravenous magnesium sulphate in the acute treatment of migraine without aura and migraine with aura. A randomized, double-blind, placebo-controlled study", Cephalalgia ,2002,22,    ,['citation-journal']," Bigal ME, Bordini CA, Tepper SJ, Speciali JG. Intravenous magnesium sulphate in the acute treatment of migraine without aura and migraine with aura. A randomized, double-blind, placebo-controlled study.  Cephalalgia 2002;22:345-53.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1046/j.1468-2982.2002.00364.x', 'https://www.ncbi.nlm.nih.gov/pubmed/12110110', 'https://scholar.google.com/scholar_lookup?title=Intravenous+magnesium+sulphate+in+the+acute+treatment+of+migraine+without+aura+and+migraine+with+aura.+A+randomized,+double-blind,+placebo-controlled+study+&author=ME+Bigal&author=CA+Bordini&author=SJ+Tepper&author=JG+Speciali&publication_year=2002&hl=en']",12110110,https://doi.org/10.1046/j.1468-2982.2002.00364.x, Bigal 2002 ,additional,CD015322-bbs2-0012,,12110110,12110110,12110110,172,,,12110110
CD015322-bib-0014,"Bigal ME, Tepper ST. ",Ergotamine and dihydroergotamine: a review, Current Pain and Headache Reports ,2003,7,    ,['citation-journal']," Bigal ME, Tepper ST. Ergotamine and dihydroergotamine: a review.  Current Pain and Headache Reports 2003;7:55-62.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1007/s11916-003-0011-7', 'https://www.ncbi.nlm.nih.gov/pubmed/12525272', 'https://scholar.google.com/scholar_lookup?title=Ergotamine+and+dihydroergotamine:+a+review&author=ME+Bigal&author=ST+Tepper&publication_year=2003&hl=en']",12525272,https://doi.org/10.1007/s11916-003-0011-7, Bigal 2003 ,additional,CD015322-bbs2-0013,,,,12525272,66,,,12525272
CD015322-bib-0015,Carlisle JB. ,"Data fabrication and other reasons for non-random sampling in 5087 randomised, controlled trials in anaesthetic and general medical journals", Anaesthesia ,2017,72,    ,['citation-journal']," Carlisle JB. Data fabrication and other reasons for non-random sampling in 5087 randomised, controlled trials in anaesthetic and general medical journals.  Anaesthesia 2017;72:944-52.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1111/anae.13938', 'https://www.ncbi.nlm.nih.gov/pubmed/28580651', 'https://scholar.google.com/scholar_lookup?title=Data+fabrication+and+other+reasons+for+non-random+sampling+in+5087+randomised,+controlled+trials+in+anaesthetic+and+general+medical+journals+&author=JB+Carlisle&publication_year=2017&hl=en']",28580651,https://doi.org/10.1111/anae.13938, Carlisle 2017 ,additional,CD015322-bbs2-0014,,28580651,28580651,28580651,199,https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/anae.13938,,28580651
CD015322-bib-0016,"Derry CJ, Derry S, Moore RA. ",Caffeine as an analgesic adjuvant for acute pain in adults, Cochrane Database of Systematic Reviews ,2014,,    ,['citation-journal']," Derry CJ, Derry S, Moore RA. Caffeine as an analgesic adjuvant for acute pain in adults.  Cochrane Database of Systematic Reviews 2014, Issue 12. Art. No: CD009281. [DOI: 10.1002/14651858.CD009281.pub3]    Link to article     Google Scholar     ","['https://doi.org/10.1002/14651858.CD009281.pub3', 'https://scholar.google.com/scholar_lookup?title=Caffeine+as+an+analgesic+adjuvant+for+acute+pain+in+adults&author=CJ+Derry&author=S+Derry&author=RA+Moore&publication_year=2014&hl=en']",,https://doi.org/10.1002/14651858.CD009281.pub3, Derry 2014a ,additional,CD015322-bbs2-0015,,,,25502052,11,https://europepmc.org/articles/pmc6485702?pdf=render,,25502052
CD015322-bib-0017,"Derry CJ, Derry S, Moore A. ",Sumatriptan (all routes of administration) for acute migraine attacks in adults ‐ overview of Cochrane reviews, Cochrane Database of Systematic Reviews ,2014,,    ,['citation-journal']," Derry CJ, Derry S, Moore A. Sumatriptan (all routes of administration) for acute migraine attacks in adults ‐ overview of Cochrane reviews.  Cochrane Database of Systematic Reviews 2014, Issue 5. Art. No: CD009108. [DOI: 10.1002/14651858.CD009108.pub2]    Link to article     Google Scholar     ","['https://doi.org/10.1002/14651858.CD009108.pub2', 'https://scholar.google.com/scholar_lookup?title=Sumatriptan+(all+routes+of+administration)+for+acute+migraine+attacks+in+adults+‐+overview+of+Cochrane+reviews+&author=CJ+Derry&author=S+Derry&author=A+Moore&publication_year=2014&hl=en']",,https://doi.org/10.1002/14651858.CD009108.pub2, Derry 2014b ,additional,CD015322-bbs2-0016,,,24865446,24865446,101,https://europepmc.org/articles/pmc6469574?pdf=render,,24865446
CD015322-bib-0018,"Dieterich M, Brandt T. ",Episodic vertigo related to migraine (90 cases): vestibular migraine?, Journal of Neurology ,1999,246,    ,['citation-journal']," Dieterich M, Brandt T. Episodic vertigo related to migraine (90 cases): vestibular migraine? Journal of Neurology 1999;246(10):883-92. [DOI: 10.1007/s004150050478]    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1007/s004150050478', 'https://www.ncbi.nlm.nih.gov/pubmed/10552234', 'https://scholar.google.com/scholar_lookup?title=Episodic+vertigo+related+to+migraine+(90+cases):+vestibular+migraine?&author=M+Dieterich&author=T+Brandt&publication_year=1999&hl=en']",10552234,https://doi.org/10.1007/s004150050478, Dieterich 1999 ,additional,CD015322-bbs2-0017,,10552234,,10552234,510,,,10552234
CD015322-bib-0019,"Dieterich M, Obermann M, Celebisoy N. ",Vestibular migraine: the most frequent entity of episodic vertigo, Journal of Neurology ,2016,263,    ,['citation-journal']," Dieterich M, Obermann M, Celebisoy N. Vestibular migraine: the most frequent entity of episodic vertigo.  Journal of Neurology 2016;263:82-9. [DOI: 10.1007/s00415-015-7905-2]    Link to article     Google Scholar     ","['https://doi.org/10.1007/s00415-015-7905-2', 'https://scholar.google.com/scholar_lookup?title=Vestibular+migraine:+the+most+frequent+entity+of+episodic+vertigo&author=M+Dieterich&author=M+Obermann&author=N+Celebisoy&publication_year=2016&hl=en']",,https://doi.org/10.1007/s00415-015-7905-2, Dieterich 2016 ,additional,CD015322-bbs2-0018,,27083888,,27083888,246,https://link.springer.com/content/pdf/10.1007/s00415-015-7905-2.pdf,,27083888
CD015322-bib-0020,"Frejo L, Giegling I, Teggi R, Lopez-Escamez JA, Rujescu D. ",Genetics of vestibular disorders: pathophysiological insights, Journal of Neurology ,2016,263,    ,['citation-journal']," Frejo L, Giegling I, Teggi R, Lopez-Escamez JA, Rujescu D. Genetics of vestibular disorders: pathophysiological insights.  Journal of Neurology 2016;263:45-53. [DOI: 10.1007/s00415-015-7988-9]    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1007/s00415-015-7988-9', 'https://www.ncbi.nlm.nih.gov/pubmed/26477026', 'https://scholar.google.com/scholar_lookup?title=Genetics+of+vestibular+disorders:+pathophysiological+insights&author=L+Frejo&author=I+Giegling&author=R+Teggi&author=JA+Lopez-Escamez&author=D+Rujescu&publication_year=2016&hl=en']",26477026,https://doi.org/10.1007/s00415-015-7988-9, Frejo 2016 ,additional,CD015322-bbs2-0019,,27083884,,27083884,72,https://link.springer.com/content/pdf/10.1007/s00415-015-7988-9.pdf,,26477026
CD015322-bib-0021,"Goadsby PJ, Edvinsson L, Ekman, R. ",Vasoactive peptide release in the extracerebral circulation of humans during migraine headache, Annals of Neurology ,1190,28,    ,['citation-journal']," Goadsby PJ, Edvinsson L, Ekman, R. Vasoactive peptide release in the extracerebral circulation of humans during migraine headache.  Annals of Neurology 1190;28:183-7.    Google Scholar     ",['https://scholar.google.com/scholar_lookup?title=Vasoactive+peptide+release+in+the+extracerebral+circulation+of+humans+during+migraine+headache+&author=PJ+Goadsby&author=L+Edvinsson&publication_year=1190&hl=en'],,, Goadsby 1990 ,additional,CD015322-bbs2-0020,,1699472,1699472,,,,,1699472
CD015322-bib-0022,"Goadsby PJ, Edvinsson L. ",The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats, Annals of Neurology ,1993,33,    ,['citation-journal']," Goadsby PJ, Edvinsson L. The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats.  Annals of Neurology 1993;33(1):48-56.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1002/ana.410330109', 'https://www.ncbi.nlm.nih.gov/pubmed/8388188', 'https://scholar.google.com/scholar_lookup?title=The+trigeminovascular+system+and+migraine:+studies+characterizing+cerebrovascular+and+neuropeptide+changes+seen+in+humans+and+cats+&author=PJ+Goadsby&author=L+Edvinsson&publication_year=1993&hl=en']",8388188,https://doi.org/10.1002/ana.410330109, Goadsby 1993 ,additional,CD015322-bbs2-0021,,8388188,8388188,8388188,1148,,,8388188
CD015322-bib-0023,"Hadjikhani N, Sanchez del Rio M, Wu O, Schwartz D, Bakker D, Fischi B, et al. ",Mechanisms of migraine aura revealed by functional MRI in human visual cortex, Proceedings of the National Academy of Sciences of the United States of America ,2001,98,    ,['citation-journal']," Hadjikhani N, Sanchez del Rio M, Wu O, Schwartz D, Bakker D, Fischi B, et al. Mechanisms of migraine aura revealed by functional MRI in human visual cortex.  Proceedings of the National Academy of Sciences of the United States of America 2001;98(8):4687-92. [DOI: 10.1073/pnas.071582498]    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1073/pnas.071582498', 'https://www.ncbi.nlm.nih.gov/pubmed/11287655', 'https://scholar.google.com/scholar_lookup?title=Mechanisms+of+migraine+aura+revealed+by+functional+MRI+in+human+visual+cortex&author=N+Hadjikhani&author=M+SanchezdelRio&author=O+Wu&author=D+Schwartz&author=D+Bakker&author=B+Fischi&publication_year=2001&hl=en']",11287655,https://doi.org/10.1073/pnas.071582498, Hadjikhani 2001 ,additional,CD015322-bbs2-0022,,,,11287655,1463,https://europepmc.org/articles/pmc31895?pdf=render,,11287655
CD015322-bib-0024,,"Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011",,,,. Available from training.cochrane.org/handbook/archive/v5.1/.   ,['citation-other']," Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from training.cochrane.org/handbook/archive/v5.1/.    ",[],,, Handbook 2011 ,additional,CD015322-bbs2-0023,,,,,,,,
CD015322-bib-0025,"Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al (editors). ","Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Cochrane, 2021",,,,. Available from training.cochrane.org/handbook.   ,['citation-other']," Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Cochrane, 2021. Available from training.cochrane.org/handbook.    ",[],,, Handbook 2021 ,additional,CD015322-bbs2-0024,,,,,,,,
CD015322-bib-0026,"Haywood K, Potter R, Froud R, Pearce G, Box B, Muldoon L, et al. ","Core outcome set for preventive intervention trials in chronic and episodic migraine (COSMIG): an international, consensus-derived and multistakeholder initiative", BMJ Open ,2021,11,    ,['citation-journal']," Haywood K, Potter R, Froud R, Pearce G, Box B, Muldoon L, et al. Core outcome set for preventive intervention trials in chronic and episodic migraine (COSMIG): an international, consensus-derived and multistakeholder initiative.  BMJ Open 2021;11(11):e043242.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1136/bmjopen-2020-043242', 'https://www.ncbi.nlm.nih.gov/pubmed/34848505', 'https://scholar.google.com/scholar_lookup?title=Core+outcome+set+for+preventive+intervention+trials+in+chronic+and+episodic+migraine+(COSMIG):+an+international,+consensus-derived+and+multistakeholder+initiative+&author=K+Haywood&author=R+Potter&author=R+Froud&author=G+Pearce&author=B+Box&author=L+Muldoon&publication_year=2021&hl=en']",34848505,https://doi.org/10.1136/bmjopen-2020-043242, Haywood 2021 ,additional,CD015322-bbs2-0025,,,34848505,34848505,28,https://bmjopen.bmj.com/content/bmjopen/11/11/e043242.full.pdf,,34848505
CD015322-bib-0027,"Hunter BR, Wang AZ, Bucca AW, Musey PI Jr, Strachan CC, Roumpf SK, et al. ",Efficacy of benzodiazepines or antihistamines for patients with acute vertigo: a systematic review and meta-analysis, JAMA Neurology ,2022,79,    ,['citation-journal']," Hunter BR, Wang AZ, Bucca AW, Musey PI Jr, Strachan CC, Roumpf SK, et al. Efficacy of benzodiazepines or antihistamines for patients with acute vertigo: a systematic review and meta-analysis.  JAMA Neurology 2022;79(9):846-55.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1001/jamaneurol.2022.1858', 'https://www.ncbi.nlm.nih.gov/pubmed/35849408', 'https://scholar.google.com/scholar_lookup?title=Efficacy+of+benzodiazepines+or+antihistamines+for+patients+with+acute+vertigo:+a+systematic+review+and+meta-analysis+&author=BR+Hunter&author=AZ+Wang&author=AW+Bucca&author=CC+Strachan&author=SK+Roumpf&publication_year=2022&hl=en']",35849408,https://doi.org/10.1001/jamaneurol.2022.1858, Hunter 2022 ,additional,CD015322-bbs2-0026,,,,35849408,22,,,35849408
CD015322-bib-0028,"Jacobsen GP, Newman CW. ",The development of the Dizziness Handicap Inventory, Archives of Otolaryngology - Head and Neck Surgery ,1990,116,    ,['citation-journal']," Jacobsen GP, Newman CW. The development of the Dizziness Handicap Inventory.  Archives of Otolaryngology - Head and Neck Surgery 1990;116(4):424-7.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1001/archotol.1990.01870040046011', 'https://www.ncbi.nlm.nih.gov/pubmed/2317323', 'https://scholar.google.com/scholar_lookup?title=The+development+of+the+Dizziness+Handicap+Inventory&author=GP+Jacobsen&author=CW+Newman&publication_year=1990&hl=en']",2317323,https://doi.org/10.1001/archotol.1990.01870040046011, Jacobsen 1990 ,additional,CD015322-bbs2-0027,,,,2317323,2200,,,2317323
CD015322-bib-0029,"Jacobsen GP, Calder JH. ",A screening version of the Dizziness Handicap Inventory, American Journal of Otology ,1998,19,    ,['citation-journal']," Jacobsen GP, Calder JH. A screening version of the Dizziness Handicap Inventory.  American Journal of Otology 1998;19(6):804-8.    PubMed     Google Scholar     ","['https://www.ncbi.nlm.nih.gov/pubmed/9831158', 'https://scholar.google.com/scholar_lookup?title=A+screening+version+of+the+Dizziness+Handicap+Inventory&author=GP+Jacobsen&author=JH+Calder&publication_year=1998&hl=en']",9831158,, Jacobsen 1998 ,additional,CD015322-bbs2-0028,,,,,,,,9831158
CD015322-bib-0030,"Jhingran P, Osterhaus JT, Miller DW, Lee JT, Kirchdoerfer L. ",Development and validation of the Migraine-Specific Quality of Life Questionnaire, Headache ,1998,38,    ,['citation-journal']," Jhingran P, Osterhaus JT, Miller DW, Lee JT, Kirchdoerfer L. Development and validation of the Migraine-Specific Quality of Life Questionnaire.  Headache 1998;38(4):295-302.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1046/j.1526-4610.1998.3804295.x', 'https://www.ncbi.nlm.nih.gov/pubmed/9595870', 'https://scholar.google.com/scholar_lookup?title=Development+and+validation+of+the+Migraine-Specific+Quality+of+Life+Questionnaire&author=P+Jhingran&author=JT+Osterhaus&author=DW+Miller&author=JT+Lee&author=L+Kirchdoerfer&publication_year=1998&hl=en']",9595870,https://doi.org/10.1046/j.1526-4610.1998.3804295.x, Jhingran 1998 ,additional,CD015322-bbs2-0029,,9595870,,9595870,223,,,9595870
CD015322-bib-0031,"Lefebvre C, Glanville J, Briscoe S, Littlewood A, Marshall C, Metzendorf M-I, et al. ",Technical Supplement to Chapter 4: Searching for and selecting studies,,,,". In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Cochrane, 2021. Available from training.cochrane.org/handbook.   ",['citation-other']," Lefebvre C, Glanville J, Briscoe S, Littlewood A, Marshall C, Metzendorf M-I, et al. Technical Supplement to Chapter 4: Searching for and selecting studies. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Cochrane, 2021. Available from training.cochrane.org/handbook.    ",[],,, Lefebvre 2020 ,additional,CD015322-bbs2-0030,,,,,,,,
CD015322-bib-0032,"Lempoert T, Neuhauser H. ","Epidemiology of vertigo, migraine and vestibular migraine", Journal of Neurology ,2009,256,    ,['citation-journal']," Lempoert T, Neuhauser H. Epidemiology of vertigo, migraine and vestibular migraine.  Journal of Neurology 2009;256:333-8. [DOI: 10.1007/s00415-009-0149-2]    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1007/s00415-009-0149-2', 'https://www.ncbi.nlm.nih.gov/pubmed/19225823', 'https://scholar.google.com/scholar_lookup?title=Epidemiology+of+vertigo,+migraine+and+vestibular+migraine&author=T+Lempoert&author=H+Neuhauser&publication_year=2009&hl=en']",19225823,https://doi.org/10.1007/s00415-009-0149-2, Lempert 2009 ,additional,CD015322-bbs2-0031,,12473755,,19225823,289,https://edoc.rki.de/bitstream/176904/616/1/25oih53z9aAfA.pdf,,19225823
CD015322-bib-0033,"Lempert T, Olesen J, Furman J, Waterston J, Seemungal B, Carey J, et al. ",Vestibular migraine: diagnostic criteria, Journal of Vestibular Research ,2012,22,    ,['citation-journal']," Lempert T, Olesen J, Furman J, Waterston J, Seemungal B, Carey J, et al. Vestibular migraine: diagnostic criteria.  Journal of Vestibular Research 2012;22:167-72.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.3233/VES-2012-0453', 'https://www.ncbi.nlm.nih.gov/pubmed/23142830', 'https://scholar.google.com/scholar_lookup?title=Vestibular+migraine:+diagnostic+criteria&author=T+Lempert&author=J+Olesen&author=J+Furman&author=J+Waterston&author=B+Seemungal&author=J+Carey&publication_year=2012&hl=en']",23142830,https://doi.org/10.3233/VES-2012-0453, Lempert 2012 ,additional,CD015322-bbs2-0032,,,,,,,,23142830
CD015322-bib-0034,"Moreno-Ajona D, P. ","Gepants, calcitonin-gene-related peptide receptor antagonists: what could be their role in migraine treatment?", Current Opinion in Neurology ,2020,33,    ,['citation-journal']," Moreno-Ajona D, P. Gepants, calcitonin-gene-related peptide receptor antagonists: what could be their role in migraine treatment? Current Opinion in Neurology 2020;33(3):309-15. [DOI: 10.1097/WCO.0000000000000806]    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1097/WCO.0000000000000806', 'https://www.ncbi.nlm.nih.gov/pubmed/32251023', 'https://scholar.google.com/scholar_lookup?title=Gepants,+calcitonin-gene-related+peptide+receptor+antagonists:+what+could+be+their+role+in+migraine+treatment?+&author=D+Moreno-Ajona&publication_year=2020&hl=en']",32251023,https://doi.org/10.1097/WCO.0000000000000806, Moreno‐Ajona 2020 ,additional,CD015322-bbs2-0033,,,,,,,,32251023
CD015322-bib-0035,"Neuhauser H, Leopold M, von Brevern M, Arnold G, Lempert T. ","The interrelations of migraine, vertigo and migrainous vertigo", Neurology ,2001,56,    ,['citation-journal']," Neuhauser H, Leopold M, von Brevern M, Arnold G, Lempert T. The interrelations of migraine, vertigo and migrainous vertigo.  Neurology 2001;56(4):436-41. [DOI: 10.1212/wnl.56.4.436]    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1212/WNL.56.4.436', 'https://www.ncbi.nlm.nih.gov/pubmed/11222783', 'https://scholar.google.com/scholar_lookup?title=The+interrelations+of+migraine,+vertigo+and+migrainous+vertigo&author=H+Neuhauser&author=M+Leopold&author=M+Brevern&author=G+Arnold&author=T+Lempert&publication_year=2001&hl=en']",11222783,https://doi.org/10.1212/WNL.56.4.436, Neuhauser 2001 ,additional,CD015322-bbs2-0034,,11222783,,,,,,11222783
CD015322-bib-0036,"Neuhauser H, Radtke A, von Brevern M, Feldmann M, Lezius F, Ziese T, et al. ",Migrainous vertigo: prevalence and impact on quality of life, Neurology ,2006,67,    ,['citation-journal']," Neuhauser H, Radtke A, von Brevern M, Feldmann M, Lezius F, Ziese T, et al. Migrainous vertigo: prevalence and impact on quality of life.  Neurology 2006;67(6):1028-33.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1212/01.wnl.0000237539.09942.06', 'https://www.ncbi.nlm.nih.gov/pubmed/17000973', 'https://scholar.google.com/scholar_lookup?title=Migrainous+vertigo:+prevalence+and+impact+on+quality+of+life&author=H+Neuhauser&author=A+Radtke&author=M+Brevern&author=M+Feldmann&author=F+Lezius&author=T+Ziese&publication_year=2006&hl=en']",17000973,https://doi.org/10.1212/01.wnl.0000237539.09942.06, Neuhauser 2006 ,additional,CD015322-bbs2-0035,,,,,,,,17000973
CD015322-bib-0037,"Pardutz A, Schoenen J. ",NSAIDs in the acute treatment of migraine: a review of clinical and experimental data, Pharmaceuticals ,2010,3,    ,['citation-journal']," Pardutz A, Schoenen J. NSAIDs in the acute treatment of migraine: a review of clinical and experimental data.  Pharmaceuticals 2010;3(6):1966-87.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.3390/ph3061966', 'https://www.ncbi.nlm.nih.gov/pubmed/27713337', 'https://scholar.google.com/scholar_lookup?title=NSAIDs+in+the+acute+treatment+of+migraine:+a+review+of+clinical+and+experimental+data&author=A+Pardutz&author=J+Schoenen&publication_year=2010&hl=en']",27713337,https://doi.org/10.3390/ph3061966, Pardutz 2010 ,additional,CD015322-bbs2-0036,,,,,,,,27713337
CD015322-bib-0038,"Pietrobon D, Striessnig J. ",Neurobiology of migraine, Nature Reviews Neuroscience ,2003,4,    ,['citation-journal']," Pietrobon D, Striessnig J. Neurobiology of migraine.  Nature Reviews Neuroscience 2003;4:386-98.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1038/nrn1102', 'https://www.ncbi.nlm.nih.gov/pubmed/12728266', 'https://scholar.google.com/scholar_lookup?title=Neurobiology+of+migraine&author=D+Pietrobon&author=J+Striessnig&publication_year=2003&hl=en']",12728266,https://doi.org/10.1038/nrn1102, Pietrobon 2003 ,additional,CD015322-bbs2-0037,,12728266,,,,,,12728266
CD015322-bib-0039,,Review Manager (RevMan),,2020,,.   ,['citation-other']," Review Manager (RevMan). Version 5.4. Copenhagen: The Cochrane Collaboration, 2020.    ",[],,, RevMan 2020 [Computer program] ,additional,CD015322-bbs2-0038,,41699371,,,,,,41699371
CD015322-bib-0040,"Russo A, Marcelli V, Esposito F, Corvino V, Marcuccio L, Giannone A, et al. ",Abnormal thalamic function in patients with vestibular migraine, Neurology ,2014,82,    ,['citation-journal']," Russo A, Marcelli V, Esposito F, Corvino V, Marcuccio L, Giannone A, et al. Abnormal thalamic function in patients with vestibular migraine.  Neurology 2014;82(23):2120-6. [DOI: 10.1212/WNL.0000000000000496]    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1212/WNL.0000000000000496', 'https://www.ncbi.nlm.nih.gov/pubmed/24814847', 'https://scholar.google.com/scholar_lookup?title=Abnormal+thalamic+function+in+patients+with+vestibular+migraine&author=A+Russo&author=V+Marcelli&author=F+Esposito&author=V+Corvino&author=L+Marcuccio&author=A+Giannone&publication_year=2014&hl=en']",24814847,https://doi.org/10.1212/WNL.0000000000000496, Russo 2014 ,additional,CD015322-bbs2-0039,,,,,,,,24814847
CD015322-bib-0041,"Smyth D, Britton Z, Murdin L, Arshad Q, Kaski D . ",Vestibular migraine treatment: a comprehensive practical review, Brain ,2022,145,    ,['citation-journal']," Smyth D, Britton Z, Murdin L, Arshad Q, Kaski D . Vestibular migraine treatment: a comprehensive practical review.  Brain 2022;145(11):3741-54. [DOI: 10.1093/brain/awac264]    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1093/brain/awac264', 'https://www.ncbi.nlm.nih.gov/pubmed/35859353', 'https://scholar.google.com/scholar_lookup?title=Vestibular+migraine+treatment:+a+comprehensive+practical+review&author=D+Smyth&author=Z+Britton&author=L+Murdin&author=Q+Arshad&publication_year=2022&hl=en']",35859353,https://doi.org/10.1093/brain/awac264, Smyth 2022 ,additional,CD015322-bbs2-0040,,35859353,,,,,,35859353
CD015322-bib-0042,"Tepper SJ, Rapoport AM, Sheftell FD. ",Mechanisms of action of the 5HT 1B/D receptor agonists, Archives of Neurology ,2002,59,    ,['citation-journal']," Tepper SJ, Rapoport AM, Sheftell FD. Mechanisms of action of the 5HT 1B/D receptor agonists.  Archives of Neurology 2002;59(7):1084-8.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1001/archneur.59.7.1084', 'https://www.ncbi.nlm.nih.gov/pubmed/12117355', 'https://scholar.google.com/scholar_lookup?title=Mechanisms+of+action+of+the+5HT+1B/D+receptor+agonists&author=SJ+Tepper&author=AM+Rapoport&author=FD+Sheftell&publication_year=2002&hl=en']",12117355,https://doi.org/10.1001/archneur.59.7.1084, Tepper 2002 ,additional,CD015322-bbs2-0041,,,,,,,,12117355
CD015322-bib-0043,"Tepper SJ, Millson D. ",Safety profile of the triptans, Expert Opinion on Drug Safety ,2003,2,    ,['citation-journal']," Tepper SJ, Millson D. Safety profile of the triptans.  Expert Opinion on Drug Safety 2003;2(2):123-32. [DOI: 10.1517/14740338.2.2.123]    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1517/14740338.2.2.123', 'https://www.ncbi.nlm.nih.gov/pubmed/12904112', 'https://scholar.google.com/scholar_lookup?title=Safety+profile+of+the+triptans&author=SJ+Tepper&author=D+Millson&publication_year=2003&hl=en']",12904112,https://doi.org/10.1517/14740338.2.2.123, Tepper 2003 ,additional,CD015322-bbs2-0042,,12904112,,,,,,12904112
CD015322-bib-0044,"Tesio L, Alpini D, Cesarani A, Perucca L. ",Short form of the Dizziness Handicap Inventory: construction and validation through Rasch analysis, American Journal of Physical Medicine and Rehabilitation ,1999,78,    ,['citation-journal']," Tesio L, Alpini D, Cesarani A, Perucca L. Short form of the Dizziness Handicap Inventory: construction and validation through Rasch analysis.  American Journal of Physical Medicine and Rehabilitation 1999;78(3):233-41.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1097/00002060-199905000-00009', 'https://www.ncbi.nlm.nih.gov/pubmed/10340421', 'https://scholar.google.com/scholar_lookup?title=Short+form+of+the+Dizziness+Handicap+Inventory:+construction+and+validation+through+Rasch+analysis+&author=L+Tesio&author=D+Alpini&author=A+Cesarani&author=L+Perucca&publication_year=1999&hl=en']",10340421,https://doi.org/10.1097/00002060-199905000-00009, Tesio 1999 ,additional,CD015322-bbs2-0043,,10340421,10340421,,,,,10340421
CD015322-bib-0045,"Tfelt-Hansen P, Saxena PR, Dahlöf C, Pascual J, Láinez M, Henry P, et al. ",Ergotamine in the acute treatment of migraine: a review and European consensus, Brain ,2000,123,    ,['citation-journal']," Tfelt-Hansen P, Saxena PR, Dahlöf C, Pascual J, Láinez M, Henry P, et al. Ergotamine in the acute treatment of migraine: a review and European consensus.  Brain 2000;123(1):9-18.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1093/brain/123.1.9', 'https://www.ncbi.nlm.nih.gov/pubmed/10611116', 'https://scholar.google.com/scholar_lookup?title=Ergotamine+in+the+acute+treatment+of+migraine:+a+review+and+European+consensus&author=P+Tfelt-Hansen&author=PR+Saxena&author=C+Dahlöf&author=J+Pascual&author=M+Láinez&author=P+Henry&publication_year=2000&hl=en']",10611116,https://doi.org/10.1093/brain/123.1.9, Tfelt‐Hansen 2000 ,additional,CD015322-bbs2-0044,,,,,,,,10611116
CD015322-bib-0046,"Vass Z, Shore SE, Nuttall AL, Miller JM. ",Direct evidence of trigeminal innervation of the cochlear blood vessels, Neuroscience ,1998,84,    ,['citation-journal']," Vass Z, Shore SE, Nuttall AL, Miller JM. Direct evidence of trigeminal innervation of the cochlear blood vessels.  Neuroscience 1998;84(11):559-67.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1016/S0306-4522(97)00503-4', 'https://www.ncbi.nlm.nih.gov/pubmed/9539226', 'https://scholar.google.com/scholar_lookup?title=Direct+evidence+of+trigeminal+innervation+of+the+cochlear+blood+vessels&author=Z+Vass&author=SE+Shore&author=AL+Nuttall&author=JM+Miller&publication_year=1998&hl=en']",9539226,https://doi.org/10.1016/S0306-4522(97)00503-4, Vass 1998 ,additional,CD015322-bbs2-0045,,9539226,9539226,,,,,9539226
CD015322-bib-0047,"Villalón CM, Olesen J. ",The role of CGRP in the pathophysiology of migraine and efficacy of CGRP receptor antagonists as acute antimigraine drugs, Pharmacological Therapy ,2009,124,    ,['citation-journal']," Villalón CM, Olesen J. The role of CGRP in the pathophysiology of migraine and efficacy of CGRP receptor antagonists as acute antimigraine drugs.  Pharmacological Therapy 2009;124(3):309-23.    Link to article     Google Scholar     ","['https://doi.org/10.1016/j.pharmthera.2009.09.003', 'https://scholar.google.com/scholar_lookup?title=The+role+of+CGRP+in+the+pathophysiology+of+migraine+and+efficacy+of+CGRP+receptor+antagonists+as+acute+antimigraine+drugs+&author=CM+Villalón&author=J+Olesen&publication_year=2009&hl=en']",,https://doi.org/10.1016/j.pharmthera.2009.09.003, Villalón 2009 ,additional,CD015322-bbs2-0046,,19796656,,,,,,19796656
CD015322-bib-0048,"Webster KE, Harrington-Benton NA, Judd O, Kaski D, Maarsingh OR, MacKeith S, et al. ",Pharmacological interventions for prophylaxis of vestibular migraine, Cochrane Database of Systematic Reviews ,2022,,    ,['citation-journal']," Webster KE, Harrington-Benton NA, Judd O, Kaski D, Maarsingh OR, MacKeith S, et al. Pharmacological interventions for prophylaxis of vestibular migraine.  Cochrane Database of Systematic Reviews 2022, Issue 3. Art. No: CD015187. [DOI: 10.1002/14651858.CD015187]    Google Scholar     ",['https://scholar.google.com/scholar_lookup?title=Pharmacological+interventions+for+prophylaxis+of+vestibular+migraine&author=KE+Webster&author=NA+Harrington-Benton&author=O+Judd&author=D+Kaski&author=OR+Maarsingh&author=S+MacKeith&publication_year=2022&hl=en'],,, Webster 2022a ,additional,CD015322-bbs2-0047,,37042522,,,,,,37042522
CD015322-bib-0049,"Webster KE, Harrington-Benton NA, Judd O, Kaski D, Maarsingh OR, MacKeith S, et al. ",Non‐pharmacological interventions for prophylaxis of vestibular migraine, Cochrane Database of Systematic Reviews ,2022,,    ,['citation-journal']," Webster KE, Harrington-Benton NA, Judd O, Kaski D, Maarsingh OR, MacKeith S, et al. Non‐pharmacological interventions for prophylaxis of vestibular migraine.  Cochrane Database of Systematic Reviews 2022, Issue 3. Art. No: CD015321. [DOI: 10.1002/14651858.CD015321]    Google Scholar     ",['https://scholar.google.com/scholar_lookup?title=Non‐pharmacological+interventions+for+prophylaxis+of+vestibular+migraine&author=KE+Webster&author=NA+Harrington-Benton&author=O+Judd&author=D+Kaski&author=OR+Maarsingh&author=S+MacKeith&publication_year=2022&hl=en'],,, Webster 2022b ,additional,CD015322-bbs2-0048,,37042522,,,,,,37042522
CD015322-bib-0050,"Zeng L, Brignardello-Petersen R, Hultcrantz M, Siemieniuk RSC, Santesso N, Traversy G et al. ",GRADE guidelines 32: GRADE offers guidance on choosing targets of GRADE certainty of evidence ratings, Journal of Clinical Epidemiology ,2021,137,    ,['citation-journal']," Zeng L, Brignardello-Petersen R, Hultcrantz M, Siemieniuk RSC, Santesso N, Traversy G et al. GRADE guidelines 32: GRADE offers guidance on choosing targets of GRADE certainty of evidence ratings.  Journal of Clinical Epidemiology 2021;137:163-75.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1016/j.jclinepi.2021.03.026', 'https://www.ncbi.nlm.nih.gov/pubmed/33857619', 'https://scholar.google.com/scholar_lookup?title=GRADE+guidelines+32:+GRADE+offers+guidance+on+choosing+targets+of+GRADE+certainty+of+evidence+ratings+&author=L+Zeng&author=R+Brignardello-Petersen&author=M+Hultcrantz&author=RSC+Siemieniuk&author=N+Santesso&publication_year=2021&hl=en']",33857619,https://doi.org/10.1016/j.jclinepi.2021.03.026, Zeng 2021 ,additional,CD015322-bbs2-0049,,,33857619,,,,,33857619
CD015322-bib-0051,"Webster KE, Harrington-Benton NA, Judd O, Kaski D, Maarsingh OR, MacKeith S, et al. ",Pharmacological interventions for acute attacks of vestibular migraine, Cochrane Database of Systematic Reviews ,2022,,    ,['citation-journal']," Webster KE, Harrington-Benton NA, Judd O, Kaski D, Maarsingh OR, MacKeith S, et al. Pharmacological interventions for acute attacks of vestibular migraine.  Cochrane Database of Systematic Reviews 2022, Issue 3. Art. No: CD015322. [DOI: 10.1002/14651858.CD015322]    Google Scholar     ",['https://scholar.google.com/scholar_lookup?title=Pharmacological+interventions+for+acute+attacks+of+vestibular+migraine&author=KE+Webster&author=NA+Harrington-Benton&author=O+Judd&author=D+Kaski&author=OR+Maarsingh&author=S+MacKeith&publication_year=2022&hl=en'],,, Webster 2022c ,other_versions,CD015322-bbs2-0050,,37042545,,,,,,37042545
